ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $631,888 | +5.9% | 176,505 | +9.2% | 0.00% | – |
Q2 2023 | $596,463 | +133.8% | 161,643 | +109.7% | 0.00% | – |
Q1 2023 | $255,128 | -5.0% | 77,078 | +11.4% | 0.00% | – |
Q4 2022 | $268,476 | +471.2% | 69,195 | +255.3% | 0.00% | – |
Q3 2022 | $47,000 | -11.3% | 19,473 | -27.3% | 0.00% | – |
Q2 2022 | $53,000 | +341.7% | 26,790 | +279.3% | 0.00% | – |
Q1 2021 | $12,000 | -14.3% | 7,063 | 0.0% | 0.00% | – |
Q4 2020 | $14,000 | -17.6% | 7,063 | 0.0% | 0.00% | – |
Q3 2020 | $17,000 | -45.2% | 7,063 | -32.5% | 0.00% | – |
Q2 2020 | $31,000 | +3.3% | 10,460 | 0.0% | 0.00% | – |
Q1 2020 | $30,000 | -26.8% | 10,460 | +3.3% | 0.00% | – |
Q4 2019 | $41,000 | +10.8% | 10,125 | +20.9% | 0.00% | – |
Q3 2019 | $37,000 | +94.7% | 8,377 | +67.0% | 0.00% | – |
Q2 2019 | $19,000 | +72.7% | 5,015 | +78.4% | 0.00% | – |
Q1 2019 | $11,000 | +57.1% | 2,811 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | -58.8% | 2,811 | 0.0% | 0.00% | – |
Q3 2018 | $17,000 | +30.8% | 2,811 | 0.0% | 0.00% | – |
Q2 2018 | $13,000 | – | 2,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |